Amneal Pharmaceuticals (AMRX) Research Hub

Amneal Pharmaceuticals (AMRX) trades on NASDAQ, US in the Healthcare (Drug Manufacturers - Specialty & Generic) sector. As of 2026-09-11, shares last closed at 17.01 USD (-1.39%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E 46.85, market cap 5.70B. This hub links to the full technical, earnings and options research available for AMRX.

Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ

SectorHealthcare (Drug Manufacturers - Specialty & Generic)
ExchangeNASDAQ, US
Last close17.01 USD (-1.39%)
52-week range15.73 USD – 19.26 USD
Trend regimeRange
14-day RSI38.7 (Bearish)
Trailing P/E46.85
Market cap5.70B
Dividend yield0.00%
Next earnings2026-07-30

Available research for AMRX

Earnings

AMRX earnings: next report 2026-07-30, real EPS beat/miss history, analyst consensus Buy, P/E 46.85. Updated 2026-07-23.

Options: Covered Call

Covered Call on AMRX: how it works, illustrative setup around the real 17.01 USD price, max profit/loss, breakeven and when to use it. Educational.

Options: Iron Condor

Iron Condor on AMRX: how it works, illustrative setup around the real 17.01 USD price, max profit/loss, breakeven and when to use it. Educational.

Options: Protective Put

Protective Put on AMRX: how it works, illustrative setup around the real 17.01 USD price, max profit/loss, breakeven and when to use it. Educational.

Technical

AMRX technical analysis: range, last 17.01 USD, RSI 38.7, 52w range 15.73 USD–19.26 USD, real support/resistance. Updated 2026-09-11.

Frequently asked questions

What sector is AMRX in?

Amneal Pharmaceuticals (AMRX) is classified under Healthcare (Drug Manufacturers - Specialty & Generic), listed on NASDAQ, US.

Is AMRX in an uptrend or downtrend?

As of 2026-09-11, AMRX is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.

What is AMRX's trailing P/E ratio?

AMRX's trailing P/E is 46.85, with a market cap of 5.70B. See the earnings research page for full valuation detail.

When does AMRX next report earnings?

AMRX is next scheduled to report earnings on 2026-07-30, with a consensus EPS estimate of 0.24 USD.